Aptose Biosciences Files 8-K
Ticker: APTOF · Form: 8-K · Filed: Jun 12, 2025 · CIK: 882361
Sentiment: neutral
Topics: disclosure, financials
Related Tickers: APTO
TL;DR
APTO filed an 8-K, standard disclosure stuff, no major news.
AI Summary
Aptose Biosciences Inc. filed an 8-K on June 12, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Lorus Therapeutics Inc. and Imutec Pharma Inc., is incorporated in Canada and has its principal executive offices in Toronto. This filing does not contain specific financial figures or material events beyond the reporting of these items.
Why It Matters
This filing indicates Aptose Biosciences Inc. is providing required disclosures and financial updates to the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- Lorus Therapeutics Inc. (company) — Former company name
- Imutec Pharma Inc (company) — Former company name
- June 12, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing by Aptose Biosciences Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on June 12, 2025.
What are the former names of Aptose Biosciences Inc. mentioned in the filing?
The former names of Aptose Biosciences Inc. mentioned are Lorus Therapeutics Inc. and Imutec Pharma Inc.
In which jurisdiction is Aptose Biosciences Inc. incorporated?
Aptose Biosciences Inc. is incorporated in Canada.
Where are the principal executive offices of Aptose Biosciences Inc. located?
The principal executive offices of Aptose Biosciences Inc. are located in Toronto.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Aptose Biosciences Inc. (APTOF).